Colorectal Cancer: Current Updates and Future Perspectives
- PMID: 38202047
- PMCID: PMC10780254
- DOI: 10.3390/jcm13010040
Colorectal Cancer: Current Updates and Future Perspectives
Abstract
Colorectal cancer is a frequent neoplasm in western countries, mainly due to dietary and behavioral factors. Its incidence is growing in developing countries for the westernization of foods and lifestyles. An increased incidence rate is observed in patients under 45 years of age. In recent years, the mortality for CRC is decreased, but this trend is slowing. The mortality rate is reducing in those countries where prevention and treatments have been implemented. The survival is increased to over 65%. This trend reflects earlier detection of CRC through routine clinical examinations and screening, more accurate staging through advances in imaging, improvements in surgical techniques, and advances in chemotherapy and radiation. The most important predictor of survival is the stage at diagnosis. The screening programs are able to reduce incidence and mortality rates of CRC. The aim of this paper is to provide a comprehensive overview of incidence, mortality, and survival rate for CRC.
Keywords: colorectal cancer; incidence; mortality; screening; survival.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
The role of artificial intelligence based systems for cost optimization in colorectal cancer prevention programs.Front Artif Intell. 2022 Sep 30;5:955399. doi: 10.3389/frai.2022.955399. eCollection 2022. Front Artif Intell. 2022. PMID: 36248620 Free PMC article. Review.
-
Colorectal cancer incidence, mortality, tumour characteristics, and treatment before and after introduction of the faecal immunochemical testing-based screening programme in the Netherlands: a population-based study.Lancet Gastroenterol Hepatol. 2022 Jan;7(1):60-68. doi: 10.1016/S2468-1253(21)00368-X. Epub 2021 Nov 22. Lancet Gastroenterol Hepatol. 2022. PMID: 34822762
-
Colorectal cancer screening of the general population in East Asia.Dig Endosc. 2016 Apr;28(3):243-9. doi: 10.1111/den.12579. Epub 2016 Feb 4. Dig Endosc. 2016. PMID: 26595883 Review.
-
Global colorectal cancer burden in 2020 and projections to 2040.Transl Oncol. 2021 Oct;14(10):101174. doi: 10.1016/j.tranon.2021.101174. Epub 2021 Jul 6. Transl Oncol. 2021. PMID: 34243011 Free PMC article. Review.
-
Characteristics of colorectal cancers among Alaska Native people before and after implementing programs to promote screening.J Cancer Policy. 2021 Sep;29:100293. doi: 10.1016/j.jcpo.2021.100293. Epub 2021 Jul 12. J Cancer Policy. 2021. PMID: 35559952 Free PMC article.
Cited by
-
Prognostic Significance of CLDN1, INHBA, and CXCL12 in Colon Adenocarcinoma: A Multi-Omics and Single-Cell Approach.Biomedicines. 2025 Apr 24;13(5):1035. doi: 10.3390/biomedicines13051035. Biomedicines. 2025. PMID: 40426863 Free PMC article.
-
Pseudogenes as Potential Diagnostic, Prognostic and Therapeutic Biomarkers in Colorectal Cancer: A Systematic Review.Cancer Rep (Hoboken). 2025 Jun;8(6):e70263. doi: 10.1002/cnr2.70263. Cancer Rep (Hoboken). 2025. PMID: 40556338 Free PMC article.
-
Promising Cellular Immunotherapy for Colorectal Cancer Using Classical Dendritic Cells and Natural Killer T Cells.Cells. 2025 Jan 22;14(3):166. doi: 10.3390/cells14030166. Cells. 2025. PMID: 39936958 Free PMC article. Review.
-
Sphincter-preserving surgical techniques in low rectal cancer management: A systematic review of contemporary evidence.World J Gastrointest Surg. 2025 Jul 27;17(7):107525. doi: 10.4240/wjgs.v17.i7.107525. World J Gastrointest Surg. 2025. PMID: 40740930 Free PMC article. Review.
-
Oral dosage forms for drug delivery to the colon: an existing gap between research and commercial applications.J Mater Sci Mater Med. 2025 Mar 5;36(1):24. doi: 10.1007/s10856-025-06868-5. J Mater Sci Mater Med. 2025. PMID: 40042550 Free PMC article. Review.
References
-
- Rocca A., Cipriani F., Belli G., Berti S., Boggi U., Bottino V., Cillo U., Cescon M., Cimino M., Corcione F., et al. The Italian Consensus on minimally invasive simultaneous resections for synchronous liver metastasis and primary colorectal cancer: A Delphi methodology. Updates Surg. 2021;73:1247–1265. doi: 10.1007/s13304-021-01100-9. - DOI - PubMed
-
- Avella P., Vaschetti R., Cappuccio M., Gambale F., De Meis L., Rafanelli F., Brunese M.C., Guerra G., Scacchi A., Rocca A. The role of liver surgery in simultaneous synchronous colorectal liver metastases and colorectal cancer resections: A literature review of 1730 patients underwent open and minimally invasive surgery. Minerva Surg. 2022;77:582–590. doi: 10.23736/S2724-5691.22.09716-7. - DOI - PubMed
-
- Carbone F., Chee Y., Rasheed S., Cunningham D., Bhogal R.H., Jiao L., Tekkis P., Kontovounisios C. Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach. Updates Surg. 2022;74:451–465. doi: 10.1007/s13304-021-01234-w. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources